EschbachJ.W., FunkD., AdamsonJ., KuhnI., ScribnerB.H., and FinchC.A.: Erythropoiesis in patients with renal failure undergoing chronic dialysis.New Eng. J. Med.276: 653, 1967.
2.
FriedW., and AnagnostouA.: Extrarenal erythropoietin production, in Kidney Hormones, Vol. II: Erythropoietin, ed. FisherJ.W., Academic Press, London, 1977, p. 231.
3.
van Ypersele de StrihouC., and StragierA.: Effect of bilateral nephrectomy on transfusion requirements of patients undergoing chronic dialysis.Lancet,2: 705, 1969.
4.
LichtmanM.A., and MillerD.R.: Erythrocyte glycolysis, 2,3-diphosphoglycerate and adenosine triphosphate concentration in uremic subjects: Relationship to extracellular phosphate concentration.J. Lab. Clin. Med.76: 267, 1970.
5.
FisherJ.W., ModderB.H., FoleyJ., OhnoY., and RegeA.B.: The role of erythropoietin and inhibitors of erythropoiesis in the mechanism of the anemia of renal insufficiency. In Kidney Hormones, Vol. II: Erythropoietin, ed. FisherJ.W., Academic Press, London, 1977, p. 551.
6.
AnagnostouA., BaroneJ., KedoA., and FriedW.: Effect of erythropoietin therapy on the red cell volume of uraemic and non-uraemic rats.Brit. J. Haemat.37: 85, 1977.
7.
WeltL.G., SachsJ.R., and McManusT.J.: An ion transport defect in erythrocytes from uremic patients.Trans. Amer. Phys.77: 169, 1964.
8.
YawataY., HoweR., and JacobH.S.: Abnormal red cell metabolism causing hemolysis in uremia.Ann. Int. Med.,70: 362, 1973.
9.
NeimanR.S., BischelM.D., and LukesR.J.: Hypersplenism in the uremic hemodialyzed patient.Am. J. Clin. Path.60: 502, 1973.
10.
WhiteheadV.M., ComtyC.H., PosenG.A., and KayM.: Homeostasis of folic acid in patients undergoing maintenance hemodialysis.New Eng. J. Med.,279: 970, 1968.
11.
FriedW., JonassonO., LangG., and SchwartzF.: The hematologic effect of androgens in uremic patients.Study of packed cell volume and erythropoietin response. Ann. Int. Med.69: 823, 1973.
12.
AdamsonJ.W.: Steroid metabolites and hemopoiesis. In Kidney Hormones, Vol. II: Erythropoietin. ed. FisherJ.W., Academic Press, London, 1977, p. 437.
13.
EschbachJ.W., and AdamsonJ.W.: Improvement in the anemia of chronic renal failure with fluoxymesterone.Ann. Int. Med.,78: 527, 1973.
14.
ShaldonS., KochK.M., OppermanF., PatynaW.D., and ShoeppeW.: Testosterone therapy of anemia in maintenance dialysis.Brit. Med. J.,3: 212, 1971.
15.
WilliamsJ.S., SteinJ.H., and FerrisT.F.: Nandrolone decanoate therapy for patients receiving hemodialysis.Arch. Int. Med.,134: 289, 1974.
16.
Editorial,: Cobalt in severe renal failure.Lancetii: 26, 1976.
17.
MiyakeT., KungC., and GoldwasserE.: Purification of human erythropoietin.J. Biol. Chem.252: 5558, 1977.
18.
Kolk VeghterA.J., BoschE., and VanLeeuwenA.M.: Influence of serum hepatitis on hemoglobin levels of patients on regular hemodialysis.Lanceti: 526, 1971.
19.
AdamsonJ.W., PopovicW.J., and BrownJ.E.: Hormonal influences on erythroid colony growth in culture. In In Vitro Aspects of Erythropoiesis. Ed. MurphyM.J.Jr., Springer Verlag, New York, 1978, p. 95.
20.
GoldeD.W.: Hormonal modulation of erythropoiesis in-vitro. In In-Vitro Aspects of Erythropoiesis. Ed. MurphyM.J.Jr., Springer Verlag, New York, 1978, p. 81.